Butofilolol

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Butofilolol
Butofilolol skeletal.svg
Systematic (IUPAC) name
(RS)-1-[2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-fluorophenyl]butan-1-one
Clinical data
Identifiers
64552-17-6 N
None
PubChem CID 68838
ChemSpider 62071 YesY
UNII 4AZC6Y5A8G YesY
ChEMBL CHEMBL157443 YesY
Synonyms CM-6805
Chemical data
Formula C17H26FNO3
311.392 g/mol
 N (what is this?)  (verify)

Butofilolol (trade name Cafide) is a beta-blocker drug for the treatment of essential hypertension (high blood pressure).[1][2] It is not known to be marketed anywhere.

References[edit]

  1. ^ Houin, G; Barre, J; Jeanniot, JP; Ledudal, P; Cautreels, W; Tillement, JP (1984). "Pharmacokinetics of butofilolol (CAFIDE) after repeated oral administration in man". International journal of clinical pharmacology research 4 (3): 175–83. PMID 6149195.  edit
  2. ^ Toussain, P; Gay, G; Debry, G (1983). "Long-term hypotensive treatment by butofilolol". Annales de cardiologie et d'angeiologie 32 (4): 277–83. PMID 6412614.  edit